Loading...
Bliss Gvs Pharma Limited — Bisacodyl Export Profile: Buyers & Destinations
Loading...
Indian Pharmaceutical Exporter · #3 for Bisacodyl · $712.9K export value · DGFT Verified
Bliss Gvs Pharma Limited is the #3 Indian exporter of Bisacodyl with $712.9K in export value and 26 verified shipments. Bliss Gvs Pharma Limited holds a 8.3% market share in Bisacodyl exports across 3 countries.
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES | $639.5K | 23 | 95.2% |
| NEW ZEALAND | $20.3K | 2 | 3.0% |
| COSTA RICA | $12.1K | 1 | 1.8% |
Bliss Gvs Pharma Limited exports Bisacodyl to 3 countries. The largest destination is UNITED STATES accounting for 95.2% of Bliss Gvs Pharma Limited's Bisacodyl shipments, followed by NEW ZEALAND (3.0%) and COSTA RICA (1.8%). These destinations reflect Bliss Gvs Pharma Limited's established distribution network and regulatory approvals in key markets.
| Buyer | Country | Value | Orders |
|---|---|---|---|
| TO THE ORDER OF | NEW ZEALAND | $316.9K | 16 |
| M S GERICARE PHARMACEUTICALS | UNITED STATES | $179.9K | 4 |
| TO THE ORDER | UNITED STATES | $135.1K | 3 |
| RISING PHARMA HOLDINGS INC DBA RISI | UNITED STATES | $17.5K | 1 |
| TO THE ORDER OF. | COSTA RICA | $12.1K | 1 |
| A F T PHARMACEUTICALS LIMITED C | NEW ZEALAND | $10.4K | 1 |
India exported $6.4M worth of Bisacodyl through 1,294 shipments from 240 suppliers to 108 countries, serving 415 buyers globally. Bliss Gvs Pharma Limited contributes $712.9K to this total, accounting for 8.3% of India's Bisacodyl exports. Bliss Gvs Pharma Limited ships Bisacodyl to 3 countries through 6 buyers.
Bliss Gvs Pharma Limited's average Bisacodyl shipment value is $27.4K per consignment, based on 26 shipments totaling $712.9K. The largest destination is UNITED STATES (95.2% of Bliss Gvs Pharma Limited's Bisacodyl exports).
Bliss Gvs Pharma Limited ranks #3 among 240 Indian Bisacodyl exporters with a 8.3% market share. The top 3 exporters are DR.REDDY'S LABORATORIES LTD ($2.0M), IND SWIFT LIMITED ($760.7K), BLISS GVS PHARMA LIMITED ($712.9K). Bliss Gvs Pharma Limited processed 26 shipments to 3 destination countries.
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| HARMLESS MEDICINE FOR HUMAN CONSUMPTIONBISACODYL SUPPOSITORIES USP 10 MGOTHERDETAILS AS PER DOCUMENT | $179.9K | 4 |
| HARMLESS MEDICINE FOR HUMAN CONSUMPTION(BISACODYL SUPPOSITORIES USP 10 MG) OTHER DETAILS AS PER INVOICENOS | $133.4K | 6 |
| PHARMACEUTICAL PRODUCT BISACODYL SUPPOSITORIES USP 10 MG OTHER DETAILS AS PER INVOICE | $92.5K | 2 |
| Harmless Medicine for Human ConsumptionPROCTOZONE B Each Suppository contains:Bisacodyl | $68.3K | 3 |
| HARMLESS MEDICINE FOR HUMAN CONSUMPTION(BISACODYL SUPPOSITORIES USP 10 MG) OTHER DETAILS AS PER INVOICE | $53.6K | 2 |
| HARMLESS MEDICINE FOR HUMAN CONSUMPTIONBISACODYL 10 HDF SUPP BISACODYL USP (10)MG EXCIPIENTS (QS.)NOS | $51.7K | 4 |
| PHARMACEUTICAL PRODUCT BISACODYL SUPPOSI | $42.5K | 1 |
| HARMLESS MEDICINE FOR HUMAN CONSUMPTIONBISACODYL 10 HDF SUPP (BISACODYL SUPPOSITORIES USP (10) MG EXCIPIENTS (QS.) |
What Bliss Gvs Pharma Limited must comply with to export Bisacodyl to its top destination countries
Approval Process
ANDA (Abbreviated New Drug Application) for generics. Indian manufacturing site must pass FDA pre-approval inspection. Drug Master File (DMF) required for APIs.
Timeline: 10–18 months for ANDA approval
GMP & Export Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA
Drug Listing with FDA; Export Certificate from CDSCO India; Import Alert screening via FDA PREDICT system
Note: Subject to FDA Import Alerts. Open Form 483 observations can block all exports from a facility.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
Exporters ranked immediately above and below #3 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 1 | DR.REDDY'S LABORATORIES LTD | $2.0M | 78 | 1 | $25.4K |
| 2 | IND SWIFT LIMITED | $760.7K | 26 | 1 | $29.3K |
| 3 | BLISS GVS PHARMA LIMITED ★ | $712.9K | 26 | 3 | $27.4K |
| 4 | DR REDDYS LABORATORIES LIMITED | $458.7K | 12 | 1 | $38.2K |
| 5 |
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR CARGO ACC (INBOM4) | 168 | 13.0% |
| NHAVA SHEVA SEA (INNSA1) | 159 | 12.3% |
| SAHAR AIR | 152 | 11.7% |
| JNPT/ NHAVA SHEVA SEA | 74 | 5.7% |
| HYDERABAD ICD | 60 | 4.6% |
| JNPT | 58 | 4.5% |
| Bombay Air | 42 | 3.2% |
| AHEMDABAD ICD | 32 | 2.5% |
Latest developments and market context
Detailed market intelligence for Bisacodyl — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Bliss Gvs Pharma Limited's Bisacodyl exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Bliss Gvs Pharma Limited supplies Bisacodyl to 6 buyers globally. The largest buyer is TO THE ORDER OF (NEW ZEALAND), followed by M S GERICARE PHARMACEUTICALS (UNITED STATES) and TO THE ORDER (UNITED STATES). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
| $17.5K |
| 1 |
| HARMLESS MEDICINE FOR HUMAN CONSUMPTION:BISACODYL10 ( EACH SUPPOSITORY CONTAINS: BISACODYL USP 10 MG ) | $12.1K | 1 |
| HARMLESS MEDICINE FOR HUMAN CONSUMPTION:LAX -SUPPOSITORIES EACH SUPPOSITORY CONTAINS: BISACODYL BP/PH.EUR.10 MG EXCIPI | $10.4K | 1 |
Bliss Gvs Pharma Limited exports 11 distinct Bisacodyl formulations including tablets, capsules, syrups, and combination drugs. The top formulation is HARMLESS MEDICINE FOR HUMAN CONSUMPTIONBISACODYL SUPPOSITORI with 4 shipments worth $179.9K.
| MEDREICH LIMITED |
| $399.9K |
| 21 |
| 5 |
| $19.0K |
Bliss Gvs Pharma Limited ranks #3 among 240 Indian Bisacodyl exporters. Average shipment value of $27.4K compared to the market average of $26.5K. The closest competitors by value are DR.REDDY'S LABORATORIES LTD and IND SWIFT LIMITED.
Verify manufacturer licensing and export certifications with the official agencies above.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 108+ countries, 415+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Access shipment-level records, pricing trends, and buyer contacts for Bliss Gvs Pharma Limited.
Request DemoView Pricing →Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Bisacodyl. For current shipment-level data, contact TransData Nexus.